Fill out the form to download the white paper.
Since its founding in 2006, ICER has become the healthcare industry cost watchdog, and the industry is paying attention. Without adequate planning for and mitigation of ICER reviews, manufacturers risk the success of their drug and the possibility of negative publicity and price cut recommendations from ICER.
But you don't have to go it alone - we've outlined 5 steps for manufacturers to prepare for an ICER review in order to ensure drug success.
In this white paper, we cover:
- ICER’s background and evaluation process
- The impact of ICER on manufacturers
- 5 steps to successfully prepare for an ICER review